Aptevo Therapeutics (APVO) EPS (Basic) Growth (5y) (2020 - 2026)
Aptevo Therapeutics (APVO) EPS (Basic) Growth (5y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - |
| 10 | Aptevo Therapeutics | 3.29 Mn | -6.51 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -14.87% |
| Mar 31, 2026 | -14.87% |
| Dec 31, 2025 | 90.42% |
| Sep 30, 2025 | -14.89% |
| Mar 31, 2025 | -14.88% |
| Dec 31, 2024 | -15.28% |
| Sep 30, 2024 | -14.97% |
| Mar 31, 2023 | 34.37% |
| Dec 31, 2022 | 1.91% |
| Sep 30, 2022 | -74.98% |
| Jun 30, 2022 | -55.90% |
| Mar 31, 2022 | -48.08% |
| Dec 31, 2021 | -48.82% |
| Sep 30, 2021 | -58.72% |
| Jun 30, 2021 | 14.90% |
| Mar 31, 2021 | 14.96% |
| Dec 31, 2020 | 22.89% |
| Sep 30, 2020 | 14.92% |